Study of Immune Response Modifier in the Treatment of Hematologic Malignancies
Clinical trial NCT00276159 · TERMINATED
Trial details
- NCT number
- NCT00276159
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2008-11-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.